# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Rosacea

Acne rosacea
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 18 results.
A Safety and Efficacy Study to Evaluate Rosacea
Status: Not yet recruiting
Last Changed: Apr 17, 2019
First Received: Mar 21, 2019
Disease(s): Papulopustular Rosacea
Intervention(s): AIV001, Vehicle
Locations: Cosmetic Laser Dermatology, San Diego, California, United States
Rosacea and Ivermectin
Status: Not yet recruiting
Last Changed: Feb 21, 2020
First Received: Feb 19, 2020
Disease(s): Rosacea
Intervention(s): ivermectin, digital interaction, GPSkin
Locations: Wake Forest Health Sciences Dermatology, Winston-Salem, North Carolina, United States
Evaluation of Topical Application of BMX-010 in Subjects With Rosacea
Status: Recruiting
Last Changed: Jan 07, 2019
First Received: Nov 28, 2018
Disease(s): Rosacea
Intervention(s): BMX-010
Locations: Colorado Skin Care, Englewood, Colorado, United States
Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea
Status: Recruiting
Last Changed: Nov 06, 2019
First Received: Nov 06, 2019
Disease(s): Erythematotelangiectatic Rosacea
Intervention(s): The Vbeam® Prima System, Oxymetazoline HCL 1% Cream
Locations: Dermatology, Laser & Vein Specialists of the Carolinas, Charlotte, North Carolina, United States
Dermatology & Laser Surgery Center, Houston, Texas, United States
Photodynamic Therapy for Papulopustular Rosacea
Status: Recruiting
Last Changed: Aug 24, 2018
First Received: Mar 03, 2014
Disease(s): Rosacea, Papulopustular Rosacea
Intervention(s): Aminolevulinic acid topical solution 20%, Blu-U Light Therapy, Placebo vehicle only
Locations: Medical Faculty Associates - George Washington University, Washington, District of Columbia, United States
Evaluation of the New Laser PHOTOLASE PLV-585nm for the Treatment of Rosacea
Status: Not yet recruiting
Last Changed: Jul 11, 2019
First Received: Oct 17, 2018
Disease(s): Erythematotelangiectatic Rosacea
Intervention(s): Excel V 532nm (KTP) green Laser, PHOTOLASE PLV 585 nm yellow laser
A Long Term Safety Study of S5G4T-1 in the Treatment of Papulopustular Rosacea
Status: Recruiting
Last Changed: Jul 10, 2019
First Received: Jun 20, 2018
Disease(s): Papulopustular Rosacea
Intervention(s): S5G4T-1
Locations: Sol-Gel 224, Rochester, New York, United States
Safety and Efficacy of Rifaximin in Patients With Papulopustular Rosacea and Positive Lactulose Breath Test
Status: Recruiting
Last Changed: Mar 11, 2019
First Received: Mar 06, 2019
Disease(s): Papulopustular Rosacea
Intervention(s): Rifaximin delayed release 400 mg tablet, Placebo
Locations: Ospedali Riuniti di Ancona, Ancona, Italy
Policlinico di Bari, Bari, Italy
Policlinico Sant'Orsola Malpighi, Bologna, Italy
Spedali Civili, Brescia, Italy
Policlinico Vittorio Emanuele, Catania, Italy
... and 8 other locations.
Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial Rosacea
Status: Recruiting
Last Changed: Oct 24, 2019
First Received: Sep 27, 2019
Disease(s): Facial Rosacea
Intervention(s): Soolantra® Ivermectin cream 1%, Ivermectin cream 1%, Placebo for Ivermectin cream 1%
Locations: Zydus Worldwide DMCC, Brandon, Florida, United States
Zydus Worldwide DMCC, Fort Lauderdale, Florida, United States
Zydus Worldwide DMCC, Miami, Florida, United States
Zydus Worldwide DMCC, Miramar, Florida, United States
Zydus Worldwide DMCC, Tampa, Florida, United States
... and 7 other locations.
Timolol for the Treatment of Acne and Rosacea
Status: Recruiting
Last Changed: Jan 10, 2020
First Received: May 17, 2016
Disease(s): Acne Vulgaris, Rosacea
Intervention(s): Timolol
Locations: Johns Hopkins Dermatology Department, Baltimore, Maryland, United States